Results for tag: "Inclusion Body Myositis"

Inclusion Body Myositis (IBM) is a rare, progressive muscle disorder that affects the muscles of the arms, legs, and trunk. It is classified as an autoimmune disorder, meaning that the body's immune system mistakenly attacks healthy muscle tissue. IBM is a type of inflammatory myopathy, which is a group of diseases that cause muscle inflammation and weakness. Symptoms of IBM include muscle weakness, fatigue, and difficulty with activities of daily living. IBM is a relatively new field within the Allergy and Immunology specialty. Research is ongoing to better understand the cause of IBM and to develop treatments. Currently, there is no cure for IBM, but treatments are available to help manage symptoms and slow the progression of the disease. Companies in the IBM market include Biogen, Novartis, and Sanofi. These companies are researching and developing treatments for IBM, as well as providing support and resources for those living with the disease. Show Less Read more